Since all organoids expressed CD277 and could thus potentially express the conformationally changed isoform serving as the TEG002 ligand, we initiated co-cultures to confirm the effector’s potency to recognize the tumor cells. The gene discussed is BTN3A1; the disease is neoplasm.